Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Mega Genomics Limited ( (HK:6667) ) has shared an announcement.
Mega Genomics Limited has declared a final ordinary cash dividend of RMB 0.15 per share for the financial year ended 31 December 2025, with shareholders approving the payout on 21 May 2026. The dividend will be paid in Hong Kong dollars at HKD 0.17 per share, based on an updated exchange rate of RMB 1 to HKD 1.15.
The stock will trade ex-dividend on 26 May 2026, with the record date set for 29 May 2026 and payment scheduled for 9 July 2026, and Tricor Investor Services Limited acting as share registrar in Hong Kong. The update focuses on the exchange rate used for conversion, providing clarity for investors on the precise Hong Kong dollar amount they will receive and underscoring the company’s commitment to returning cash to shareholders.
More about Mega Genomics Limited
Mega Genomics Limited is a Hong Kong-listed company in the genomics sector, though the announcement focuses on its role as an equity issuer rather than detailing specific products or services. The company is overseen by a board comprising executive, non-executive and independent non-executive directors, reflecting a standard listed-company governance structure.
Average Trading Volume: 6,348
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$1.59B
For detailed information about 6667 stock, go to TipRanks’ Stock Analysis page.